173 related articles for article (PubMed ID: 8668678)
1. The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D.
Bodmeier R; Guo X; Sarabia RE; Skultety PF
Pharm Res; 1996 Jan; 13(1):52-6. PubMed ID: 8668678
[TBL] [Abstract][Full Text] [Related]
2. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit RS 30D.
Wu C; McGinity JW
Pharm Dev Technol; 2003; 8(1):103-10. PubMed ID: 12665203
[TBL] [Abstract][Full Text] [Related]
3. The effect of the ratio of two acrylic polymers on the in vitro release kinetics of ketoprofen from pellets prepared by extrusion and spheronisation technique.
Kibria G; Ul-Jalil R
Pak J Pharm Sci; 2008 Apr; 21(2):92-7. PubMed ID: 18390436
[TBL] [Abstract][Full Text] [Related]
4. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
Wulff R; Leopold CS
Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
[TBL] [Abstract][Full Text] [Related]
5. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
Ibekwe VC; Fadda HM; Parsons GE; Basit AW
Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
[TBL] [Abstract][Full Text] [Related]
6. Controlled release of acidic drugs in compendial and physiological hydrogen carbonate buffer from polymer blend-coated oral solid dosage forms.
Wulff R; Rappen GM; Koziolek M; Garbacz G; Leopold CS
Eur J Pharm Sci; 2015 Sep; 77():246-53. PubMed ID: 26093053
[TBL] [Abstract][Full Text] [Related]
7. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
[TBL] [Abstract][Full Text] [Related]
8. Influence of chloride ion exchange on the permeability and drug release of Eudragit RS 30 D films.
Wagner K; McGinity J
J Control Release; 2002 Aug; 82(2-3):385-97. PubMed ID: 12175751
[TBL] [Abstract][Full Text] [Related]
9. Influence of ibuprofen as a solid-state plasticizer in Eudragit RS 30 D on the physicochemical properties of coated beads.
Wu C; McGinity JW
AAPS PharmSciTech; 2001 Nov; 2(4):24. PubMed ID: 14727861
[TBL] [Abstract][Full Text] [Related]
10. An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid.
Narisawa S; Nagata M; Hirakawa Y; Kobayashi M; Yoshino H
J Pharm Sci; 1996 Feb; 85(2):184-8. PubMed ID: 8683446
[TBL] [Abstract][Full Text] [Related]
11. Tackiness of acrylic and cellulosic polymer films used in the coating of solid dosage forms.
Wesseling M; Kuppler F; Bodmeier R
Eur J Pharm Biopharm; 1999 Jan; 47(1):73-8. PubMed ID: 10234529
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions.
Tang X; Tai LY; Yang XG; Chen F; Xu HM; Pan WS
Drug Dev Ind Pharm; 2013 Jan; 39(1):67-76. PubMed ID: 22339718
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
Nath B; Nath LK; Kumar P
Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
[TBL] [Abstract][Full Text] [Related]
14. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.
Bonferoni MC; Rossi S; Ferrari F; Stavik E; Pena-Romero A; Caramella C
AAPS PharmSciTech; 2000 Jun; 1(2):E15. PubMed ID: 14727848
[TBL] [Abstract][Full Text] [Related]
15. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
Kaur K; Kim K
Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
[TBL] [Abstract][Full Text] [Related]
16. Preparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylic polymers and studies on mechanisms of drug-polymer interactions.
Pignatello R; Ferro M; Puglisi G
AAPS PharmSciTech; 2002; 3(2):E10. PubMed ID: 12916947
[TBL] [Abstract][Full Text] [Related]
17. Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism.
Wulff R; Leopold CS
AAPS PharmSciTech; 2016 Apr; 17(2):493-503. PubMed ID: 26265188
[TBL] [Abstract][Full Text] [Related]
18. Effect of substitution of plasticizer dibutyl phthalate with dibutyl sebacate on Eudragit
Chaudhary RS; Patel T; Kumar JR; Chan M
Pharm Dev Technol; 2019 Mar; 24(3):276-282. PubMed ID: 29688126
[TBL] [Abstract][Full Text] [Related]
19. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
20. The influence of surfactants and additives on drug release from a cationic eudragit coated multiparticulate diltiazem formulation.
Heinicke G; Schwartz JB
Pharm Dev Technol; 2007; 12(4):381-9. PubMed ID: 17763143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
